ARK Autonomous Technology & Robotics ETF vs Mesoblast Limited — how do they compare? ARK Autonomous Technology & Robotics ETF trades at $128.49, while Mesoblast Limited trades at $16.68 (market cap $2.21B). The key difference: ARK Autonomous Technology & Robotics ETF is trading nearer its 52-week high, Mesoblast Limited nearer its low. Which is the better fit depends on your goals.
| ARKQ | MESO | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $143.82 | $20.96 |
52-Week Low | $95.28 | $12.88 |
Market Cap | — | $2.21B |
Enterprise Value | — | $2.21B |
Trailing returns across standard periods
ARKQ is an actively managed ETF that invests in autonomous technology and robotics. It focuses on disruptive innovations like autonomous mobility, electric vehicles, 3D printing, and energy storage, with holdings such as Tesla and Teradyne.
Read more on ARKQ →Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →